Ditran (JB-329) is an anticholinergic drug mixture, related to the chemical warfare agent 3-Quinuclidinyl benzilate (QNB). Ditran is composed of a mixture of 70% 1-ethyl-2-pyrrolidinylmethyl-alpha- phenylcyclopentylglycolate and 30% 1-ethyl-3-piperidyl-alpha-phenylcyclopentylglycolate. These compounds are structural isomers and have very similar pharmacological properties. The piperidine compound is the more potent of the two and the reason the mixture was used was because of ease of manufacture, however it is also possible to make the piperidine compound in its pure form, so there were ultimately two forms of Ditran used in research, the original 70/30 mix, and "Ditran-B", the pure piperidine compound. Ditran was developed during chemical weapons research in an attempt to produce non-leth
| Attributes | Values |
|---|
| rdf:type
| |
| rdfs:label
| |
| rdfs:comment
| - Ditran (JB-329) is an anticholinergic drug mixture, related to the chemical warfare agent 3-Quinuclidinyl benzilate (QNB). Ditran is composed of a mixture of 70% 1-ethyl-2-pyrrolidinylmethyl-alpha- phenylcyclopentylglycolate and 30% 1-ethyl-3-piperidyl-alpha-phenylcyclopentylglycolate. These compounds are structural isomers and have very similar pharmacological properties. The piperidine compound is the more potent of the two and the reason the mixture was used was because of ease of manufacture, however it is also possible to make the piperidine compound in its pure form, so there were ultimately two forms of Ditran used in research, the original 70/30 mix, and "Ditran-B", the pure piperidine compound. Ditran was developed during chemical weapons research in an attempt to produce non-leth (en)
- Ditran – potencjalny psychotoksyczny bojowy środek trujący o silnym działaniu halucynogennym. Jest mieszaniną dwóch izomerycznych związków chemicznych z grupy fenyloglikolanów:
* N-etylo-3-pirolidylometylofenylocyklopentyloglikolanu (70%; Ditran I)
* N-etylo-3-piperydylofenylocyklopentyloglikolanu (30%; Ditran II) Identyfikacja:
* numer CAS: 8015-54-1 (pl)
|
| foaf:depiction
| |
| dct:subject
| |
| Wikipage page ID
| |
| Wikipage revision ID
| |
| Link from a Wikipage to another Wikipage
| |
| sameAs
| |
| dbp:wikiPageUsesTemplate
| |
| thumbnail
| |
| c
| |
| CAS number
| |
| ChEMBL
| |
| H
| |
| IUPAC name
| - mixture of methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate and -2-cyclopentyl-2-hydroxy-2-phenylacetate (en)
|
| n
| |
| O
| |
| PubChem
| |
| UNII
| |
| Verifiedfields
| |
| verifiedrevid
| |
| Watchedfields
| |
| width
| |
| has abstract
| - Ditran (JB-329) is an anticholinergic drug mixture, related to the chemical warfare agent 3-Quinuclidinyl benzilate (QNB). Ditran is composed of a mixture of 70% 1-ethyl-2-pyrrolidinylmethyl-alpha- phenylcyclopentylglycolate and 30% 1-ethyl-3-piperidyl-alpha-phenylcyclopentylglycolate. These compounds are structural isomers and have very similar pharmacological properties. The piperidine compound is the more potent of the two and the reason the mixture was used was because of ease of manufacture, however it is also possible to make the piperidine compound in its pure form, so there were ultimately two forms of Ditran used in research, the original 70/30 mix, and "Ditran-B", the pure piperidine compound. Ditran was developed during chemical weapons research in an attempt to produce non-lethal incapacitating agents, similar to QNB itself. The ditran mixture is more potent as an anticholinergic than the piperidyl benzilate drugs such as N-methyl-3-piperidyl benzilate, but is less potent than QNB. There has been a modest amount of scientific research using this mixture, but most modern research using these kinds of anticholinergic drugs uses N-methyl-3-piperidyl benzilate due to its wider availability. (en)
- Ditran – potencjalny psychotoksyczny bojowy środek trujący o silnym działaniu halucynogennym. Jest mieszaniną dwóch izomerycznych związków chemicznych z grupy fenyloglikolanów:
* N-etylo-3-pirolidylometylofenylocyklopentyloglikolanu (70%; Ditran I)
* N-etylo-3-piperydylofenylocyklopentyloglikolanu (30%; Ditran II) Ditran powoduje trwające 20-24 godzin psychozy o objawach przypominających choroby psychiczne. Dawki doustne rzędu 5–15 mg powodują rozszerzenie źrenic, osłabienie mięśni, suchość w jamie ustnej i podwyższenie tętna. Po około godzinie stopniowo pojawiają się zaburzenia mowy, utrudniona koncentracja i orientacja, następnie silne halucynacje (wzrokowe, słuchowe i dotykowe), całkowicie wyłączające człowieka z otaczającej rzeczywistości. W niektórych przypadkach powoduje brak reakcji na bodźce zewnętrzne. Identyfikacja:
* numer CAS: 8015-54-1 (pl)
|
| gold:hypernym
| |
| prov:wasDerivedFrom
| |
| page length (characters) of wiki page
| |
| CAS number
| |
| ChEMBL
| |
| FDA UNII code
| |
| PubChem
| |
| foaf:isPrimaryTopicOf
| |
| is Link from a Wikipage to another Wikipage
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)
